Patents Assigned to Fairfield Clinical Trials, LLC
-
Publication number: 20110086023Abstract: The invention provides a topical pharmaceutical composition for application to the nasal or ocular mucosa which comprises (1) a pharmaceutical excipient suitable for topical administration, (2) a mucosal adjuvant, (3) an antihistamine drug and (4) a mast cell stabilizer, a non-steroidal anti-inflammatory drug, a phosphodiesterase inhibitor, an anti-IgE agent, heparin, a topical steroid or a leukotriene blocker.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Fairfield Clinical Trials LLCInventor: Edward M. Lane
-
Publication number: 20090304826Abstract: The invention provides a method and composition for treating dermatoses by topical application of a composition containing an antihistamine, an NSAID and optionally a botanical medicinal compound. The compositions are useful for skin conditions such as inflammatory skin conditions, including eczema, atopic dermatitis, non-allergic dermatitis, psoriasis and rosacea, or any inflammation of the skin.Type: ApplicationFiled: June 1, 2009Publication date: December 10, 2009Applicant: Fairfield Clinical Trials, LLCInventor: Edward M. Lane
-
Publication number: 20090306025Abstract: The invention provides a method and compound for treating darkness and/or swelling/inflammation of the skin of humans. An antihistamine compound and a non-steroidal anti-inflammatory drug (NSAID) compound in combination have been found to effectively treat under eye darkness, swelling and puffiness in particular, when applied topically to the affected skin.Type: ApplicationFiled: June 1, 2009Publication date: December 10, 2009Applicant: Fairfield Clinical Trials, LLCInventor: Edward M. Lane
-
Publication number: 20080085302Abstract: The present invention relates to methods and compositions for improved efficacy and delivery of time-dependent antimicrobial drug compositions to a patient. Transdermal dosage forms and methods for steady-state delivery of drug to produce and maintain a serum concentration of drug above the minimum inhibitory concentration or minimum microbicidal concentration are provided.Type: ApplicationFiled: December 4, 2007Publication date: April 10, 2008Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20080085301Abstract: The present invention relates to methods and compositions for improved efficacy and delivery of time-dependent antimicrobial drug compositions to a patient. Transdermal dosage forms and methods for steady-state delivery of drug to produce and maintain a serum concentration of drug above the minimum inhibitory concentration or minimum microbicidal concentration are provided.Type: ApplicationFiled: December 4, 2007Publication date: April 10, 2008Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20070160591Abstract: The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing during this period or for general application and to enable the person receiving the nutritional supplementation to achieve maximum healing and rapid recovery from a procedure or injury.Type: ApplicationFiled: March 19, 2007Publication date: July 12, 2007Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Patent number: 7205007Abstract: The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing during this period or for general application and to enable the person receiving the nutritional supplementation to achieve maximum healing and rapid recovery from a procedure or injury.Type: GrantFiled: October 4, 2005Date of Patent: April 17, 2007Assignee: Fairfield Clinical Trials, LLCInventor: Edward M. Lane
-
Publication number: 20070078116Abstract: This invention relates to a method of treating otitis externa, and in particular otitis externa of fungal etiology, using topical medication, including antifungal agents such as itraconazole and miconazole, and optionally also including a second antifungal agent, which is formulated for topical application to the external ear canal, preferably as an ear drop in liquid form.Type: ApplicationFiled: October 5, 2006Publication date: April 5, 2007Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20070054844Abstract: This invention relates to a method of treating otitis externa using a topical combination medication, including one or more antifungal agent such as, for example fluconazole, voriconazole, itraconazole, clotrimazole, amphotericin B, caspofungin, micafungin, terbinafine, naftifine, butenafine, amorolfine, ravuconazole, posaconazole, flucytosine, econazole, enilaconazole, miconazole, oxiconazole, saperconazole, sulconazole, terconazole, tioconazole, nikkomycin Z, anidulafungin (LY303366), nystatin, pimaricin, griseofulvin, ciclopirox, haloprogin, tolnaftate, and undecylenate and one or more antibacterial agent such as neomycin sulfate, polymyxin B sulfate, colistin sulfate, gentamycin, tobramycin, chloramphenicol, ciprofloxacin, ofloxacin, a penicillin compound, a cephalosporin compound, a macrolide compound, a fluoroquinolone compound, streptomycin, or kanamycin.Type: ApplicationFiled: September 21, 2006Publication date: March 8, 2007Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20060263350Abstract: The invention provides a topical pharmaceutical composition for application to the nasal or ocular mucosa which comprises (1) a pharmaceutical excipient suitable for topical administration, (2) a mucosal adjuvant, (3) an antihistamine drug and (4) a mast cell stabilizer, a non-steroidal anti-inflammatory drug, a phosphodiesterase inhibitor, an anti-IgE agent, heparin, a topical steroid or a leukotriene blocker.Type: ApplicationFiled: July 28, 2006Publication date: November 23, 2006Applicant: Fairfield Clinical Trials LLCInventor: Edward Lane
-
Publication number: 20060228306Abstract: The invention provides a topical pharmaceutical composition for application to the nasal or ocular mucosa which comprises (1) a pharmaceutical excipient suitable for topical administration, (2) an antihistamine drug and (3) a mast cell stabilizer, a non-steroidal anti-inflammatory drug, a phosphodiesterase inhibitor, an anti-IgE agent, heparin, a topical steroid or a leukotriene blocker.Type: ApplicationFiled: March 27, 2006Publication date: October 12, 2006Applicant: Fairfield Clinical Trials LLCInventor: Edward Lane
-
Publication number: 20060222692Abstract: The present invention relates to methods and compositions for improved efficacy and delivery of time-dependent antimicrobial drug compositions to a patient. Transdermal dosage forms and methods for steady-state delivery of drug to produce and maintain a serum concentration of drug above the minimum inhibitory concentration or minimum microbicidal concentration are provided.Type: ApplicationFiled: March 31, 2005Publication date: October 5, 2006Applicant: Fairfield Clinical Trials LLCInventor: Edward Lane
-
Publication number: 20060207596Abstract: The present invention relates to dual nasal spray applicator devices and systems for administration of two nasal compositions in one spray or aerosol dose without mixing of the compositions prior to administration and methods of treatment using these devices and systems. The devices allow incompatible drug or other compositions to be stored and administered by a single device in a single dose, remaining separated until just prior to or during administration of the medications.Type: ApplicationFiled: September 30, 2005Publication date: September 21, 2006Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20060046998Abstract: The present invention relates to compositions and methods for initial treatment of GERD and LPRD using a proton pump inhibitor drug administered concomitantly with a histamine H2 receptor inhibitor, either transdermally or orally.Type: ApplicationFiled: August 25, 2005Publication date: March 2, 2006Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20060029587Abstract: The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing during this period or for general application and to enable the person receiving the nutritional supplementation to achieve maximum healing and rapid recovery from a procedure or injury.Type: ApplicationFiled: October 4, 2005Publication date: February 9, 2006Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20050281868Abstract: The present invention relates to transdermal drug delivery systems for the safer delivery of statin drugs to provide lessened danger or severity of side effects.Type: ApplicationFiled: June 21, 2005Publication date: December 22, 2005Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane
-
Publication number: 20050043251Abstract: This invention relates to a method of treating otitis externa, and in particular otitis externa of fungal etiology, using topical medication, including antifungal agents such as, for example fluconazole, voriconazole, itraconazole, clotrimazole, amphotericin B, caspofungin (Cancidas®), micafungin (Mycamine®), terbinafine, naftifine, butenafine, amorolfine, ravuconazole, posaconazole, flucytosine, econazole, enilaconazole, miconazole, oxiconazole, saperconazole, sulconazole, terconazole, tioconazole, nikkomycin Z, anidulafungin (LY303366), nystatin, pimaricin, griseofulvin, ciclopirox, haloprogin, tolnaftate, and undecylenate.Type: ApplicationFiled: February 5, 2004Publication date: February 24, 2005Applicant: Fairfield Clinical Trials, LLCInventor: Edward Lane